Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET
Zomedica Corp. (ZOMDF), a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, has scheduled its Q1 2025 earnings conference call for Thursday, May 15, 2025, at 4:30 p.m. ET. The call will cover operational and financial highlights for the quarter ended March 31, 2025, followed by a Q&A session.
Participants can join via phone at +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International). A replay will be available until May 29, 2025, accessible by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International) with pin 1148151.
Zomedica Corp. (ZOMDF), un'azienda nel settore della salute veterinaria specializzata in prodotti diagnostici e terapeutici point-of-care per animali equini e da compagnia, ha programmato la sua conference call per i risultati del primo trimestre 2025 per giovedì 15 maggio 2025 alle 16:30 ET. La chiamata tratterà i principali dati operativi e finanziari relativi al trimestre conclusosi il 31 marzo 2025, seguita da una sessione di domande e risposte.
I partecipanti potranno unirsi telefonicamente chiamando il numero +1-800-717-1738 (numero verde USA) o +1-646-307-1865 (internazionale). La registrazione della chiamata sarà disponibile fino al 29 maggio 2025, accessibile componendo il numero +1-844-512-2921 (USA) o +1-412-317-6671 (internazionale) con il pin 1148151.
Zomedica Corp. (ZOMDF), una empresa de salud veterinaria especializada en productos diagnósticos y terapéuticos point-of-care para animales equinos y de compañía, ha programado su conferencia telefónica de resultados del primer trimestre de 2025 para el jueves 15 de mayo de 2025 a las 4:30 p.m. ET. La llamada cubrirá los aspectos operativos y financieros del trimestre finalizado el 31 de marzo de 2025, seguida de una sesión de preguntas y respuestas.
Los participantes pueden unirse por teléfono llamando al +1-800-717-1738 (línea gratuita en EE.UU.) o al +1-646-307-1865 (internacional). Una repetición estará disponible hasta el 29 de mayo de 2025, accesible marcando +1-844-512-2921 (EE.UU.) o +1-412-317-6671 (internacional) con el pin 1148151.
Zomedica Corp. (ZOMDF)는 말과 반려동물을 위한 현장 진단 및 치료 제품을 전문으로 하는 수의학 건강 회사로, 2025년 1분기 실적 컨퍼런스 콜을 2025년 5월 15일 목요일 오후 4시 30분 ET에 예정하고 있습니다. 이번 콜에서는 2025년 3월 31일로 종료된 분기의 운영 및 재무 하이라이트를 다루며, 이후 질의응답 시간이 이어집니다.
참석자는 미국 무료 전화 +1-800-717-1738 또는 국제 전화 +1-646-307-1865로 참여할 수 있습니다. 재청취는 2025년 5월 29일까지 가능하며, +1-844-512-2921(미국) 또는 +1-412-317-6671(국제) 번호에 핀 1148151을 입력하여 접속할 수 있습니다.
Zomedica Corp. (ZOMDF), une entreprise spécialisée dans la santé vétérinaire proposant des produits diagnostiques et thérapeutiques point-of-care pour les chevaux et les animaux de compagnie, a programmé sa conférence téléphonique sur les résultats du premier trimestre 2025 pour le jeudi 15 mai 2025 à 16h30 ET. L'appel couvrira les points forts opérationnels et financiers du trimestre clos le 31 mars 2025, suivi d'une séance de questions-réponses.
Les participants peuvent rejoindre la conférence par téléphone au +1-800-717-1738 (numéro vert aux États-Unis) ou au +1-646-307-1865 (international). Une rediffusion sera disponible jusqu'au 29 mai 2025, accessible en composant le +1-844-512-2921 (États-Unis) ou le +1-412-317-6671 (international) avec le code 1148151.
Zomedica Corp. (ZOMDF), ein Unternehmen im Bereich der veterinärmedizinischen Gesundheitsversorgung, das sich auf Point-of-Care-Diagnostik- und Therapieprodukte für Pferde und Begleittiere spezialisiert hat, hat seine Telefonkonferenz zu den Quartalsergebnissen Q1 2025 für Donnerstag, den 15. Mai 2025 um 16:30 Uhr ET angesetzt. Die Telefonkonferenz behandelt operative und finanzielle Highlights für das Quartal zum 31. März 2025, gefolgt von einer Fragerunde.
Teilnehmer können sich telefonisch unter +1-800-717-1738 (gebührenfrei in den USA) oder +1-646-307-1865 (international) einwählen. Eine Aufzeichnung steht bis zum 29. Mai 2025 zur Verfügung und ist unter +1-844-512-2921 (USA) oder +1-412-317-6671 (international) mit der PIN 1148151 abrufbar.
- None.
- None.
ANN ARBOR, MI / ACCESS Newswire / May 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2025. A question-and-answer session will follow management's prepared remarks.
Event: Zomedica First Quarter 2025 Earnings Call
Date: Thursday, May 15, 2025
Time: 4:30 p.m. Eastern Time
Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)
Webcast: LINK
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, May 29, 2025 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1148151.
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices, along with the TRUFORMA® diagnostic platform, TRUVIEW® digital cytology system, VETGuardian® no-touch monitoring system, and VETIGEL® hemostatic gel, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds
Follow Zomedica
Email Alerts: http://investors.zomedica.com
Facebook: https://m.facebook.com/zomedica
X (formerly Twitter): https://twitter.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc
Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555
SOURCE: Zomedica Corp.
View the original press release on ACCESS Newswire